Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: sulfa (sulfonamides) / percocet / vicodin / adhesive tape attending: chief complaint: chest pain major surgical or invasive procedure: coronary artery bypass graft x 3 (lima to lad, svg to om, svg to pda) history of present illness: 76 y/o female with known cad s/p stent to lcx in who presented to osh with progressive chest pain. past medical history: coronary artery disease s/p lcx stent , lymphoma s/p chemo, hyperlipidemia, diabetes mellitus social history: quit smoking 19yr ago and 30 pk yr hx. denies etoh use. family history: non-contributory physical exam: vs: 62 18 151/79 5'5" 90.7 gen: nad skin: unremarkable heent: eomi, perrl, ncat neck: supple, from -jvd chest: ctab -w/r/r heart: rrr -c/r/m/g abd: soft, nt/nd +bs ext: warm, well-perfused, trace edema, superficial varcicosities neuro: a&o x 3, mae, non-focal pertinent results: echo: pre-cpb: lv systolic fxn appears normal in the face of moderate mr. echo contrast is seen in the left atrial appendage. right ventricular chamber size and free wall motion are normal. there are complex (>4mm) atheroma in the descending thoracic aorta. the aortic valve leaflets (3) are mildly thickened. no aortic regurgitation is seen. the mitral valve leaflets are moderately thickened. moderate (2+) mitral regurgitation is seen. there is no pericardial effusion. in performing the 1st graft (lad) off pump, the patient became very ischemic and fibrillated. decision made to go on pump for the rest of the grafts. post-cpb: good biventricular systolic fxn. mr remains 2+. no ai. aorta intact. 10:55am blood wbc-11.2*# rbc-2.11*# hgb-6.5*# hct-19.1*# mcv-91 mch-30.8 mchc-34.0 rdw-13.8 plt ct-129* 07:40am blood wbc-14.0* rbc-2.91* hgb-8.9* hct-26.2* mcv-90 mch-30.7 mchc-34.2 rdw-14.2 plt ct-165 10:55am blood pt-17.4* ptt-39.7* inr(pt)-1.6* 11:57am blood pt-12.9 ptt-31.8 inr(pt)-1.1 11:57am blood urean-19 creat-0.9 cl-111* hco3-22 07:40am blood glucose-195* urean-20 creat-1.2* na-135 k-4.7 cl-99 hco3-28 angap-13 06:30am blood wbc-13.2* rbc-2.71* hgb-8.5* hct-24.1* mcv-89 mch-31.3 mchc-35.1* rdw-14.4 plt ct-183 06:30am blood glucose-130* urean-22* creat-1.1 na-136 k-4.0 cl-96 hco3-31 angap-13 , csurg fa6a sched chest (portable ap) clip # reason: eval pneumothoraces medical condition: 76 year old woman s/p cabg reason for this examination: eval pneumothoraces final report history: cabg, to evaluate pneumothoraces. findings: in comparison with the study of , slight decrease in the bilateral pleural effusions. the remainder of the examination is unchanged in this patient with midline sternal sutures. picc line remains in place. dr. approved: fri 10:30 am imaging lab brief hospital course: ms. was a same day admit after undergoing pre-operative work-up when she had her cardiac cath on . on day of admission she was brought to the operating room where she underwent a coronary artery bypass graft x 3. please see operative report for surgical details. following surgery she was brought to the cvicu for invasive monitoring in stable condition. later on op day she was weaned from sedation, awoke neurologically intact and extubated. on post-op day one she was started on diuretics, beta-blockers, and some pre-op medications. later on this day she was transferred to the telemetry floor for further care. the remainder of her postop course was essentially uneventful and she was ready for discharge to home with vna services on pod#4.she has been advised to follow up with her pcp/cardiologist/ oncologist and dr.. medications on admission: aspirin 81mg qd, plavix 75mg qd(last dose 7/17), zetia 10mg qd, glyburide 2.5mg qd, metformin 500mg qd, lopressor 50mg , imdur 30mg qd, lipitor 10mg qd discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 4. hydromorphone 2 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 5. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*1* 6. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*1* 7. glyburide 2.5 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*1* 8. furosemide 20 mg tablet sig: two (2) tablet po once a day for 7 days. disp:*14 tablet(s)* refills:*0* 9. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day for 7 days. disp:*7 tab sust.rel. particle/crystal(s)* refills:*0* 10. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). disp:*1 1* refills:*0* 11. zetia 10 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*0* 12. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 13. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 14. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) inhalation four times a day as needed for shortness of breath or wheezing. disp:*1 * refills:*0* 15. ipratropium bromide 0.02 % solution sig: one (1) inhalation four times a day as needed for shortness of breath or wheezing. disp:*1 * refills:*0* discharge disposition: home with service facility: vna discharge diagnosis: coronary artery disease s/p coronary artery bypass graft x 3 pmh: lymphoma s/p chemo, hyperlipidemia, diabetes mellitus discharge condition: good discharge instructions: 1) monitor wounds for signs of infection. these include redness, drainage or increased pain. in the event that you have drainage from your sternal wound, please contact the at (. 2) report any fever greater then 100.5. 3) report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week. 4) no lotions, creams or powders to incision until it has healed. you may shower and wash incision. gently pat the wound dry. please shower daily. no bathing or swimming for 1 month. use sunscreen on incision if exposed to sun. 5) no lifting greater then 10 pounds for 10 weeks. 6) no driving for 1 month. 7) call with any questions or concerns. followup instructions: dr. in 4 weeks dr. weeks dr. in weeks md procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries transfusion of packed cells diagnoses: coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other malignant lymphomas, unspecified site, extranodal and solid organ sites chronic total occlusion of coronary artery 

Answer: The patient is high likely exposed to